Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

66.70
-0.9800-1.45%
Post-market: 66.41-0.2900-0.43%19:30 EDT
Volume:1.59M
Turnover:106.77M
Market Cap:12.89B
PE:176.00
High:68.34
Open:67.55
Low:66.52
Close:67.68
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:0.90
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:2.04
PE(LYR):37.06

Loading ...

U.S. Stocks on the MOVE-BioMarin Pharmaceutical, Home Depot, Klarna Group

Reuters
·
Aug 18

BioMarin Pharmaceutical's Alesta Deal Strengthens Long-Term Growth Outlook, Wedbush Says

MT Newswires Live
·
Aug 18

Biomarin Pharmaceutical Inc. : H.c. Wainwright Cuts Target Price to $59 from $60

THOMSON REUTERS
·
Aug 18

BioMarin Adds Potential Bone-Disease Treatment to Portfolio

Dow Jones
·
Aug 18

BioMarin Agrees to Buy Alesta Therapeutics for USD 275 Million Upfront

Reuters
·
Aug 18

Biomarin to Acquire Alesta Therapeutics to Gain Ale1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to Biomarin's Pipeline

THOMSON REUTERS
·
Aug 18

Biomarin Pharmaceutical - Deal Expected to be Modestly Dilutive to 2026 Financial Results

THOMSON REUTERS
·
Aug 18

Biomarin Pharmaceutical - Alesta Shareholders Eligible for up to $215 Mln in Milestone Payments

THOMSON REUTERS
·
Aug 18

Biomarin Pharmaceutical - Alesta to Spin Out Non-Ale1 Assets and Employees Before Close

THOMSON REUTERS
·
Aug 18

Biomarin Pharmaceutical - to Fund Acquisition with Cash on Hand

THOMSON REUTERS
·
Aug 18

BioMarin Pharmaceutical is Maintained at Overweight by Piper Sandler

Dow Jones
·
Aug 18

BioMarin price target raised to $88 from $82 at Piper Sandler

TIPRANKS
·
Aug 17

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 17

U.S. Research Roundup- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies

Reuters
·
Aug 17

Biomarin Pharmaceutical Inc. : Piper Sandler Raises Target Price to $88 from $82

THOMSON REUTERS
·
Aug 17

BioMarin (BMRN) Is Up 5.6% After Raising 2026 Revenue Outlook and Filing ESOP Shelf Registration

Simply Wall St.
·
Aug 17

BioMarin to Present at Canaccord Genuity Annual Growth Conference

Reuters
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 08

BioMarin price target raised to $86 from $80 at BofA

TIPRANKS
·
Aug 07